Prestige Consumer Healthcare Inc. last reported quarterly results on Nov 5, 2026, for Q2 FY2027 (the quarter ended Sep 30, 2026): revenue of $336.3 million (+22.7% year over year) and diluted EPS of $0.53. It usually reports 36–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 4, 2027.
Results for Q3 FY2027, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 5, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 5, 2026
36 days after quarter end
|
Q2 FY2027
ended Sep 30, 2026
|
336
+22.7%
|
25
-40.1%
|
0.53
-38.4%
|
|
Aug 6, 2026
37 days after quarter end
|
Q1 FY2027
ended Jun 30, 2026
|
266
+6.5%
|
29
-38.5%
|
0.61
-35.8%
|
|
May 13, 2026
43 days after quarter end
|
Q4 FY2026
ended Mar 31, 2026
|
282
-5.0%
|
54
+7.6%
|
1.13
+12.9%
|
|
Feb 5, 2026
36 days after quarter end
|
Q3 FY2026
ended Dec 31, 2025
|
283
-2.4%
|
47
-23.5%
|
0.97
-20.5%
|
|
Nov 6, 2025
37 days after quarter end
|
Q2 FY2026
ended Sep 30, 2025
|
274
-3.4%
|
42
-22.4%
|
0.86
-21.1%
|
|
Aug 7, 2025
38 days after quarter end
|
Q1 FY2026
ended Jun 30, 2025
|
250
-6.6%
|
47
-3.3%
|
0.95
-3.1%
|
|
May 8, 2025
38 days after quarter end
|
Q4 FY2025
ended Mar 31, 2025
|
297
+7.0%
|
50
+1.4%
|
1.00
+1.9%
|
|
Feb 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Dec 31, 2024
|
290
+2.7%
|
61
+15.1%
|
1.22
+15.1%
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBH (NYSE)
- Fiscal year ends
- March 31
- Headquarters
- Tarrytown, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1295947
- Former names
- Prestige Brands Holdings, Inc. (until Aug 10, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.